-
Implantable cardioverter defibrillator (ICD) implantation may contribute to a lower incidence of ventricular fibrillation (VF)-related out-of-hospital cardiac arrest treated by emergency medical services (EMS), according to a study published in the September issue of Heart Rhythm, a journal of the Heart Rhythm Society (formerly NASPE; Natick, Massachusetts).
-
Abiomed (Danvers, Massachusetts) named Frank Menzler general manager for Abiomed BV, the company's European division. Menzler most recently was marketing manager for cardiac surgery for Guidant Europe and was a co-founder of Impella Cardiotechnik AG, a developer of minimally invasive blood pumps.
-
Guidant (Indianapolis) said that the FDA has approved an expanded indication for the companys portfolio of cardiac resynchronization therapy defibrillators (CRT-D).
-
Congestive heart failure (CHF) is a major and growing worldwide public health problem that is creating demands for a wide range of diagnostic, therapeutic and patient-monitoring technologies in Europe and most other developed regions.
-
Several sessions held during last months congress of the European Society of Cardiology (ESC; Sophia Antipolis, France) in Munich, Germany, focused on the diabetic state of patients with coronary artery disease.
-
GE Healthcare (Waukesha, Wisconsin) has unveiled what it touted as the visual stethoscope of the future, a new, miniaturized cardiovascular ultrasound system it said was so small and lightweight that it will transform the way doctors see and treat heart disease.
-
The FDA has granted clearance to a product that may shock some consumers literally. Philips Medical Systems (Bothell, Washington) got the nod from the FDA in mid-September to market its HeartStart Home Defibrillator over the counter for the treatment of sudden cardiac arrest (SCA), the first such clearance in the U.S.
-
-
This article focuses on specific populations presenting with abdominal pain to the ED and their specific or unique diagnoses. The pediatric, elderly, pregnant, and immunocompromised patients are special populations that pose a particular challenge to clinicians. These high-risk groups often present atypically, and serious conditions can be missed or misdiagnosed. This article discusses unusual diagnoses that often present with abdominal pain as one of the main symptoms.
-
